Bristol Myers nabs new FDA nod as Breyanzi brings CAR-T class to chronic lymphocytic leukemia
Bristol Myers nabs new FDA nod as Breyanzi brings CAR-T class to chronic lymphocytic leukemia aliu Thu, 03/14/2024 - 13:54
Bristol Myers nabs new FDA nod as Breyanzi brings CAR-T class to chronic lymphocytic leukemia aliu Thu, 03/14/2024 - 13:54
NICE not sold on Vertex, CRISPR's groundbreaking sickle cell gene therapy Casgevy without more data zbecker Thu, 03/14/2024 - 11:25
Biocon continues to divest with $150M sale of insulin and other brands to Eris kdunleavy Thu, 03/14/2024 - 11:17
Charles River inks viral vector production pact for Navega's chronic pain gene therapy fkansteiner Thu, 03/14/2024 - 09:54
Biotech trade group pledges support for BIOSECURE Act, plans to boot member WuXi AppTec esagonowsky Wed, 03/13/2024 - 17:52
Merck takes Keytruda patent dispute with Johns Hopkins University from the court to the patent office zbecker Wed, 03/13/2024 - 17:49
Coherus again axes staff, with 30% of roles on chopping block amid ‘sharpened focus’ on cancer drugs aliu Wed, 03/13/2024 - 17:34